We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mobile Suitcase Laboratory Rapid Detects Visceral Leishmaniasis

By LabMedica International staff writers
Posted on 15 Jun 2016
Leishmania donovani (LD) is a protozoan parasite transmitted to humans from sand flies, which causes Visceral Leishmaniasis (VL) and currently, the diagnosis is based on presence of the anti-LD antibodies and clinical symptoms.

Molecular diagnosis would require real-time polymerase chain reaction (qPCR), which is not easy to implement at field settings; however a recombinase polymerase amplification (RPA) assay has been developed and tested for the detection of LD.

Scientists at the Georg-August-University (Gottingen, Germany) and their colleagues tested a total of 48 archived DNA samples from VL patients, asymptomatic individuals and post-kala-azar dermal leishmaniasis (PKDL) patients were tested by both RPA and real-time PCR assays. More...
To determine the specificity of the assay, the archived DNA samples including 35 endemic healthy controls, five non-endemic healthy controls and disease controls including six malaria cases and two tuberculosis cases were also investigated.

All VL, PKDL and asymptomatic cases were positive for LD DNA by realtime PCR, while controls (healthy and disease) were negative for rK39, direct antiglobulin test (DAT) and LD DNA by real-time PCR. Quantitative detection of Leishmania DNA was performed on a CFX96 real time detection system (Bio-Rad, Hercules CA, USA). Two mobile suitcase laboratories were constructed to have separate workspaces for nucleic acid extraction and detection in order to avoid any possible contamination. Blood samples were collected from seven patients hospitalized at the Surya Kanta Kala-azar Research Center, and nucleic acid was extracted from whole blood and RPA test was performed in the field.

The LD RPA assay detected equivalent to one LD genomic DNA. The assay was performed at constant temperature of 42 °C in 15 minutes. The RPA assay also detected other Leishmania species (L. major, L. aethiopica and L. infantum), but did not identify nucleic acid of other pathogens. Forty-eight samples from VL, asymptomatic and post-kala-azar dermal leishmaniasis subjects were detected positive and 48 LD-negative samples were negative by both LD RPA and real-time PCR assays, which indicates 100 % agreement. The suitcase laboratory was successfully operated at the local hospital by using a solar-powered battery. DNA extraction was performed by a novel magnetic bead based method (SpeedXtract, Qiagen, Hilden, Germany), in which a simple fast lysis protocol was applied. Moreover, all reagents were cold-chain independent.

The authors concluded that the use of a mobile suitcase laboratory is advantageous for rapid, sensitive and specific detection of LD using SpeedXtract and RPA assay, especially, at low resource settings such as Bangladesh and could contribute to VL control and elimination program. The study was published in the May 2016 issue of the journal Parasites &Vectors.

Related Links:
Georg-August-University
Bio-Rad
Qiagen

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.